Loading…
ITOC
iTonic Holdings Ltd
NASDAQ· Healthcare· Medical Devices· CUSIP G71399102
$0.32-2.43%Price as of Aug 29, 18:50 UTC · updated once a day, after the close
Key metrics
- Market cap
- $7.83M
- P/E
- —
- Forward P/E
- —
- P/B
- 0.9x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.31
- ROE
- -71.25%
- Profit margin
- 0.00%
- Revenue growth
- +91.60%
- Beta
- —
- 52-week high
- $1.18
- 52-week low
- $0.22
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -94.8% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 2 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 |
|---|---|---|---|
| Year-end price | $0.42 | $4.41 | |
| P/S | — | 13.7x | 140.2x |
| P/B | — | 1.2x | 10.2x |
| EPS | — | -$0.05 | |
| Profit margin | — | -974.68% | -147.39% |
| ROE | — | -83.26% | -10.68% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SKYESkye Bioscience, Inc. | $1.78 | — | — | — | -233.87% | $7.86M |
| AIMAIM ImmunoTech Inc. | $0.26 | — | 1.0x | — | -2382.30% | $7.87M |
| TRIBTrinity Biotech PLC | $9.68 | — | — | — | — | $7.87M |
| ENSCEnsysce Biosciences, Inc. | $0.40 |
About the company
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
- 7
- Beijing, China
Company description provided by Yahoo Finance.